Wilmington, DE and Ashdod, Israel, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring ...
Wilmington, DE and Ashdod, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack ®, a non-invasive device for measuring ...
ASHKELON, Israel--(BUSINESS WIRE)--Integrity Applications, Inc. (OTC/QB: IGAP) announced today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood glucose measurement ...
WILMINGTON, Del. & ASHDOD, Israel--(BUSINESS WIRE)--Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack ®, a non-invasive device for measuring glucose levels in people with Type 2 ...
Integrity Applications Common Stock is Publicly Quoted on the OTC Bulletin Board under the Symbol "I
Integrity Applications Common Stock is Publicly Quoted on the OTC Bulletin Board under the Symbol "IGAP" Raises approximately $6.3 million to advance the development and commercialization of ...
Integrity Applications Receives CE Mark Approval for Its GlucoTrack® Model DF-F Glucose Monitoring D
ASHKELON, Israel--(BUSINESS WIRE)-- Integrity Applications, Inc. (OTC/QB: IGAP) announced today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood glucose measurement ...
Integrity Applications Receives CE Mark Approval for Its GlucoTrack® Model DF-F Glucose Monitoring D
Integrity Applications Receives CE Mark Approval for Its GlucoTrack® Model DF-F Glucose Monitoring Device ASHKELON, Israel--(BUSINESS WIRE)-- Integrity Applications, Inc. (OTC/QB: IGAP) announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback